Skip to content
Connect Career

Data Science Applications

Bringing data to the end-users.

Deep Learning with Histologic Images

We use well-established convolutional neural network (CNN) architectures to create predictive image classification models on supervised training datasets. To this end, we can work with both weak (patient-level) annotations and strong (tissue or cell-level) annotations for the training data set. For whole-slide image data, we employ either image tiling or an in-house developed cell-based data representation to reduce the data size and burden on compute hardware.

We used this approach to predict the 5-year relapse risk of colon cancer patients from fm-IHC image crops stained with a marker panel targeting multiple immune cell phenotypes and tumor markers.

Molecular Tumor Board

Tumor boards are meetings of cancer experts, including oncologists, radiologists and other professions, to discuss the next treatment steps for cancer patients. To help them make informed decisions based on reliable data, our FusionViewer molecular tumor board aims to provide them with data and insights obtained from different biological layers of the patient, including NGS, metabolomics, flow cytometry, histologic imaging, and others. To complete the holistic picture of each patient, relevant clinical data features are extracted from unstructured electronic healthcare records (EHR) using natural language processing pipelines.

Compared to existing tumor board software solutions, FusionViewer integrates omics and non-omics data from multiple sources and shows them directly in conjunction with all available clinical data.

We use on-premise hosted structured databases to store all data required for visualizations in a secure and anonymized way. Locally hosted web-applications access these databases to bring the data to the end-users through a simple, installation-free web interface.

Drug Screening Analysis Pipeline

We support our in-house ex-vivo compound screening platform with automated statistical analysis and reporting. This includes the calculation of quality control metrics, the automatic fitting of drug response curves to dozens of compounds, and the creation of standardized reports to help doctors make better-informed decisions in complex situations. One crucial aspect of this process is the final data visualization to make sure that end-users can retrieve all relevant information easily, while at the same time providing in-depth details should they be required.

Synthetic Data

Our goal is to become the leading expert center in the practical application of synthetic histologic images. This aims at making synthetic images useful for training knowledge extraction pipelines and to substitute real image data whenever a specialized hypothesis or research task demands the expansion of existing image data sets. Our methods range from procedural algorithms to machine-learning methods, depending on the size and availability of existing, real image data and the a priori knowledge about the image content. A first showcase of using a combination of procedural cell-based image content generation and a generative adversarial network for the generation of multiplex IHC images of murine pancreatic islets shows promising results of this approach for solving complex research questions.